Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers illuminate inner workings of enzymes placed inside the outer envelopes of cells

Researchers illuminate inner workings of enzymes placed inside the outer envelopes of cells

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

Senesco completes cohort 3 of SNS01-T Phase 1b/2a trial for multiple myeloma and lymphoma treatment

FDA grants QIDP status to Astellas' isavuconazole for treatment of invasive aspergillosis

FDA grants QIDP status to Astellas' isavuconazole for treatment of invasive aspergillosis

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

A new approach for treating colorectal cancer

A new approach for treating colorectal cancer

Researchers discover promising new approach for colorectal cancer treatment

Researchers discover promising new approach for colorectal cancer treatment

Study uncovers mechanisms that allow stem cells to keep dividing in perpetuity

Study uncovers mechanisms that allow stem cells to keep dividing in perpetuity

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Freiburg scientists discover substance that suppresses unchecked cell division in leukemia cells

Freiburg scientists discover substance that suppresses unchecked cell division in leukemia cells

CSHL identifies specific stretch of DNA that helps cancerous blood cells to proliferate in AML

CSHL identifies specific stretch of DNA that helps cancerous blood cells to proliferate in AML

Two separate studies yield key findings for prevention, diagnosis, treatment and cure for AML

Two separate studies yield key findings for prevention, diagnosis, treatment and cure for AML

Researchers identify potential therapeutic target in treatment of certain AML

Researchers identify potential therapeutic target in treatment of certain AML

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

Research: Notch protein plays essential role in triggering T-cell development

Research: Notch protein plays essential role in triggering T-cell development

Scientists find link between airborne allergies and risk of blood cancers in women

Scientists find link between airborne allergies and risk of blood cancers in women

Researchers discover new genetic risk factor for schizophrenia, bipolar disorder

Researchers discover new genetic risk factor for schizophrenia, bipolar disorder

Young adults who had childhood cancer more likely to be frail than their peers

Young adults who had childhood cancer more likely to be frail than their peers

Kiadis reports successful Phase II enrollment for CR-AIR-007 ATIR blood cancer treatment study

Kiadis reports successful Phase II enrollment for CR-AIR-007 ATIR blood cancer treatment study

Childhood cancer survivors face heart problems decades after treatment

Childhood cancer survivors face heart problems decades after treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.